Biomat on microfluidic chip
Closed · Belgium
Source: Keep.EU
The treatment of patients will in the future be increasingly focused on 'personal regenerative medicine'. This is a new form of medicine in which doctors treat patients by creating new skin, bone or even an organ from cultured cells and biomaterials. This form of medicine generates great expectations in terms of innovative and personal care, but also has major challenges because it requires much h
- Status
- Closed
- Sector
- Advanced Electronics, Manufacturing (Industrial), Education, Hospital, Government, Consumer Products, Bridge, Hotel, Residential
- Location
- Belgium
- Updated
- 22 Jul 2026
- Source
- Keep.EU
ConstructChat
Ask ConstructChat about Biomat on microfluidic chip
Pick a question to edit it, or write your own.
First answer free · no account
Project Information FAQ
Project Information
Participants
Sponsoring Agency |
Status
Original status | Closed |
Taiyo status | Closed |
Taiyo last update | 2026-07-22 |
Contact
| Not available for this record. |
Description
Description | The treatment of patients will in the future be increasingly focused on 'personal regenerative medicine'. This is a new form of medicine in which doctors treat patients by creating new skin, bone or even an organ from cultured cells and biomaterials. This form of medicine generates great expectations in terms of innovative and personal care, but also has major challenges because it requires much high-quality knowledge and technology. Both Belgium and the Netherlands want to develop a knowledge economy to find answers to new challenges and at the same time to sustainably strengthen employment in the region. Platforms such as the Flemish RegMed and the Dutch Brightlands already support new developments within healthcare. To be able to test biomaterials on a large scale, a so-called 'organ-on-chip' offers new possibilities. These are small plates that mimic an organ or tissue and on which new biomaterials can be tested immediately in a physical environment. To develop this chip and prepare it for a broad introduction and use, a strong partnership is required consisting of both academic and industrial partners. 'Biomat' therefore creates a brand new microfluidic chip: the 'organ-on-chip 2.0'. This chip is seeded with stem cells to mimic a body's own organ or tissue, provided with supply and discharge of micro-fluid and sensitive sensors to perform measurements. The innovative aspect of this chip is the three-dimensional (3D) environment that is formed, in contrast to classic cell culture plates in which cells or tissues grow on a flat surface. Moreover, microfluidics - very small channels through which liquids are transported - mimic the transport of bodily fluids. To demonstrate the functionality of this revolutionary technology, examples will be constructed based on three types of clinical applications: bone, muscle and on-chip vascularized bone or muscle. |
Budget |
Location
Country | Belgium |
Source
Source reliability | Medium |
Source | Keep.EU |
URL |
More Details
Record type | Project |
Sector | Advanced Electronics, Manufacturing (Industrial), Education, Hospital, Government, Consumer Products, Bridge, Hotel, Residential |
Article published date | 2023-07-05 |
Research
Free account
View all details
You are reading the public part. A free account opens the rest:
- Every detail on this project
- News and media coverage
- Technical research
Free account · no card · lands you back on this project
